CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activityApril C. Watt, Shom Goel, Paloma Cejas et al.|Nature Cancer|2020Cited by 110
Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory CancersPer Hydbring, Piotr Siciński, Jan M. Suski et al.|Cancer Cell|2017Cited by 98
Integrative Multiomic Profiling of Triple-Negative Breast Cancer for Identifying Suitable TherapiesBojana Jovanović, Shom Goel|Clinical Cancer Research|2024Cited by 11
A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast CancerShom Goel, Sara M. Tolaney|Clinical Cancer Research|2025Cited by 7